EVENTI

CD22-targeted chimeric antigen receptor-­modified T cells for children and adults with relapse of B-­cell acute lymphoblastic leukemia after CD19-­ directed immunotherapy
Dott.ssa Giovanna Lucchini (ASST San Gerardo – Monza, Centro Trapianti di Midollo Osseo)

Link https://meet.google.com/ddb-bwbh-ync